Status:

WITHDRAWN

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Lead Sponsor:

Barbara Ann Karmanos Cancer Institute

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Prostate Cancer

Eligibility:

MALE

Phase:

PHASE3

Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. Giving radiation therapy in different ways may kill more tumor cells. It is not yet known which t...

Detailed Description

OBJECTIVES: * Compare the efficacy of neutron and photon radiotherapy vs hypofractionated intensity modulated radiation, in terms of a lower frequency of chronic complication rate (chronic toxicity a...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed adenocarcinoma of the prostate
  • Stage I-III disease (T1-T3, N0, M0)
  • No clinical or radiographic evidence of metastasis
  • If prostate-specific antigen (PSA) ≥ 10.0 ng/mL and Gleason score is 7, a radioisotope bone scan must show no evidence of metastasis
  • No evidence of lymphatic or visceral metastases of the abdomen or pelvis on CT scan or MRI
  • PSA ≤ 20 ng/mL
  • Gleason score ≤ 7 (if stage T3 , score must be \< 7)
  • PATIENT CHARACTERISTICS:
  • Performance status
  • Not specified
  • Life expectancy
  • More than 10 years
  • Hematopoietic
  • Not specified
  • Hepatic
  • Not specified
  • Renal
  • Not specified
  • Other
  • No other malignancy within the past 5 years except basal cell or squamous cell skin cancer
  • PRIOR CONCURRENT THERAPY:
  • Endocrine therapy
  • Prior hormonal therapy allowed provided it was initiated no more than 2 months ago, and may include the following:
  • Luteinizing hormone-releasing hormone agonists (e.g., goserelin, leuprolide)
  • Anti-androgens (e.g., flutamide, bicalutamide)
  • Radiotherapy
  • No prior pelvic irradiation
  • Surgery
  • No prior radical prostatectomy

Exclusion

    Key Trial Info

    Start Date :

    May 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2006

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00258466

    Start Date

    May 1 2005

    End Date

    November 1 2006

    Last Update

    April 8 2013

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.